Heart failure: the role for mineralocorticoid receptor antagonists by Bertram Pitt

Get full text

Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease by Bertram Pitt, Charles T Stier, Sanjay Rajagopalan

Get full text

Histone deacetylase inhibitors for cardiovascular conditions and healthy longevity by João Pedro Ferreira, MD, Bertram Pitt, ProfMD, Faiez Zannad, ProfMD

Get full text

Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone by Nicholas Chiu, Rahul Aggarwal, George L. Bakris, Bertram Pitt, Deepak L. Bhatt

Get full text

SOTAGLIFLOZIN SIGNIFICANTLY REDUCES CARDIOVASCULAR DEATH, MYOCARDIAL INFARCTION, AND STROKE IN THE SCORED TRIAL by Deepak L. Bhatt, Michael Szarek, Bertram Pitt, Ph Gabriel Steg, on behalf of the SCORED Investigators

Get full text

Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients by Robert D. Brook, Niko Kaciroti, George Bakris, Björn Dahlöf, Bertram Pitt, Eric Velazquez, Michael Weber, Dion H. Zappe, Tsushung Hau, Kenneth A. Jamerson

Get full text

FINERENONE IN CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES: A FIDELITY ANALYSIS OF LEFT VENTRICULAR HYPERTROPHY by Luis Matavelli, Gerasimos Filippatos, Stefan D. Anker, George L. Bakris, Peter Rossing, Luis M. Ruilope, Luke Roberts, Meike Brinker, Alfredo Farjat, Bertram Pitt

Get full text

A preliminary study on the relationship between sleep, depression and cardiovascular dysfunction in a 4 sample population by Adrienne-Denise V. Bilbao, Jennifer Goldschmied, Angela Jang, Daniel Ehrmann, Neeraj Kaplish, Bertram Pitt, Todd Arnedt, Srijan Sen, Gregory Dalack, Patricia J. Deldin

Get full text

Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials by George L Bakris, Peter Rossing, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Shweta Bansal, Maria E F Canziani, Rita Birne, Luis M Ruilope, Alfredo E Farjat, Peter Kolkhof, Andrea Lage, Meike Brinker

Get full text

Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial by Corrado De Marco, Brian L. Claggett, Simon deDenus, Michael R. Zile, Thao Huynh, Akshay S. Desai, Martin G. Sirois, Scott D. Solomon, Bertram Pitt, Jean L. Rouleau, Marc A. Pfeffer, Eileen O'Meara

Get full text

Subcutaneous Furosemide in Heart Failure by Domenic A. Sica, MD, Pieter Muntendam, MD, Rene L. Myers, PhD, Jozine M. ter Maaten, MD, PhD, Mark E. Sale, MD, Rudolf A. de Boer, MD, PhD, Bertram Pitt, MD

Get full text

Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials by John M. Flack, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luis M. Ruilope, Peter Rossing, Sharon G. Adler, Linda Fried, Kenneth Jamerson, Robert Toto, Meike Brinker, Alfredo E. Farjat, Peter Kolkhof, Robert Lawatscheck, Amer Joseph, George L. Bakris

Get full text

Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis by Sylvia E. Rosas, Luis M. Ruilope, Stefan D. Anker, Bertram Pitt, Peter Rossing, Andres Angelo Cadena Bonfanti, Ricardo Correa-Rotter, Fernando González, Carlos Francisco Jaramillo Munoz, Pablo Pergola, Guillermo E. Umpierrez, Andrea Scalise, Charlie Scott, Robert Lawatscheck, Amer Joseph, George L. Bakris

Get full text